[go: up one dir, main page]

GB0618168D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0618168D0
GB0618168D0 GBGB0618168.9A GB0618168A GB0618168D0 GB 0618168 D0 GB0618168 D0 GB 0618168D0 GB 0618168 A GB0618168 A GB 0618168A GB 0618168 D0 GB0618168 D0 GB 0618168D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0618168.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Babraham Institute
Original Assignee
Babraham Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Babraham Institute filed Critical Babraham Institute
Priority to GBGB0618168.9A priority Critical patent/GB0618168D0/en
Publication of GB0618168D0 publication Critical patent/GB0618168D0/en
Priority to PCT/GB2007/003527 priority patent/WO2008032105A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0618168.9A 2006-09-15 2006-09-15 Compounds Ceased GB0618168D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0618168.9A GB0618168D0 (en) 2006-09-15 2006-09-15 Compounds
PCT/GB2007/003527 WO2008032105A2 (en) 2006-09-15 2007-09-17 Flavonoid derivatives and their uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0618168.9A GB0618168D0 (en) 2006-09-15 2006-09-15 Compounds

Publications (1)

Publication Number Publication Date
GB0618168D0 true GB0618168D0 (en) 2006-10-25

Family

ID=37309975

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0618168.9A Ceased GB0618168D0 (en) 2006-09-15 2006-09-15 Compounds

Country Status (2)

Country Link
GB (1) GB0618168D0 (en)
WO (1) WO2008032105A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2464645B (en) 2007-07-31 2010-11-24 Limerick Biopharma Inc Quercetin-3'-O-phosphate and its uses
CN102272129B (en) * 2009-01-03 2014-10-08 静冈县公立大学法人 Sulfated c-glycoside, method for isolating same and method for synthesizing same
BR112012019529A2 (en) 2010-02-12 2019-09-24 N30 Pharmaceuticals Llc d-nitrosoglutathione reductase inhibitors
DK2533637T3 (en) 2010-02-12 2014-05-19 N30 Pharmaceuticals Inc Chromone inhibitors of S-nitrosoglutathione reductase
HRP20151405T1 (en) 2010-10-08 2016-01-15 Nivalis Therapeutics, Inc. NEW SUBSTITUTED QUINOLINE COMPOUNDS AS S-NITROSOGLUTATION REDUCTASE INHIBITORS
CN102010453A (en) * 2010-11-03 2011-04-13 杨达 Flavonol glycosides compound extracted from loropetalum chinense leaf and medicinal application thereof
RU2013127155A (en) 2010-12-16 2015-01-27 Н30 Фармасьютикалс, Инк. NEW SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHION-REDUCTASE INHIBITORS
JP2013234148A (en) * 2012-05-09 2013-11-21 Oriza Yuka Kk Vascularization suppressant
SI3071203T1 (en) 2013-11-18 2021-07-30 Forma Therapeutics, Inc. Tetrahydroquinoline compositions as bet bromodomain inhibitors
WO2015074081A1 (en) 2013-11-18 2015-05-21 Bair Kenneth W Benzopiperazine compositions as bet bromodomain inhibitors
CN103951721B (en) * 2014-05-05 2016-08-24 南京瑞菁医药科技有限责任公司 The application in treatment lipid metabolism disorder of the Quercetin-O-glycosides derivative
CN104710394B (en) * 2015-03-12 2017-09-19 中国药科大学 Coumestrol ring-opened analogs and their medicinal uses
WO2017044766A1 (en) 2015-09-10 2017-03-16 Nivalis Therapeutics, Inc. Solid forms of an s-nitrosoglutathione reductase inhibitor
US20210379012A1 (en) * 2018-04-30 2021-12-09 Indiana University Research And Technology Corporation Antiangiogenic chromane derivative and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414207A (en) * 1980-08-25 1983-11-08 American Cyanamid Company Rutin poly(H-)sulfate salts and related compounds
MXPA04006039A (en) * 2001-12-19 2004-09-27 The Quigley Corp Methods for the treatment of peripheral neural and vascular ailments.
CN101001670B (en) * 2004-05-18 2012-10-03 澳美制药厂有限公司 Composition for sleep disorders
WO2006045096A2 (en) * 2004-10-20 2006-04-27 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
CN100537560C (en) * 2006-01-24 2009-09-09 郭萍 A polymethoxyflavone derivative with anticancer activity, pharmaceutical composition, preparation method and application thereof

Also Published As

Publication number Publication date
WO2008032105A3 (en) 2008-10-09
WO2008032105A2 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
EP1984379A4 (en) Anti-arenaviral compounds
GB0605786D0 (en) Compounds
GB0606876D0 (en) Compounds
GB0618168D0 (en) Compounds
EP2082022A4 (en) Compounds
GB0607175D0 (en) Compounds
GB0605785D0 (en) Compounds
GB0605784D0 (en) Compounds
EP2004174A4 (en) Naphthalenedione compounds
GB0606913D0 (en) Compounds
GB0602042D0 (en) Compounds
AP2009004767A0 (en) Cubstituted azolin-2-yl-amino compounds
EP1973905A4 (en) Compounds
GB0600427D0 (en) Compounds
GB0602560D0 (en) Compounds
GB0602412D0 (en) Compounds
GB0607397D0 (en) Compounds
GB0600929D0 (en) Compounds
GB0602558D0 (en) Compounds
GB0602559D0 (en) Compounds
GB0602134D0 (en) Compounds
GB0602454D0 (en) Compounds
GB0602040D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)